ppm1d mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy
Published 5 years ago • 2.6K plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
1:39
clonal hematopoiesis in the cancer setting
-
50:30
nature webinar: profiling clonal hematopoiesis in cancer survivors with single-cell dna sequencing
-
5:54
dnmt3ar882 mutations perturb hematopoietic progenitors via selective hypomethylation
-
34:10
bryan kestenbaum, md, ms - clonal hematopoiesis and the kidneys
-
3:47
what is clonal hematopoiesis of indeterminate potential (chip)?
-
42:23
clone wars in mds/pre-mds: cuss, chips and aml
-
5:47
parsing out blood stem cells
-
37:15
single-cell identification of smm clones driving myeloma progression and therapy resistance
-
4:51
identifying myeloid-driven biologies
-
1:00
precision oncology in endometrial cancer
-
9:02
pd1/ ctla4 : upfront or sequentially?
-
5:42
inhibition of pd-l1 using drug mpdl3280a for patients with metastatic urothelial bladder cancer.
-
1:38
dr. usmani on pd-1/pd-l1 inhibitors in hematologic malignancies
-
2:11
allohsct in hodgkin lymphoma post pd-1 inhibitors
-
1:20
mohamad e. allaf, md, on non-metastatic renal cell cancer patients and adjuvant therapy
-
2:12
cancer immunotherapy | the pd-l1 pathway
-
10:31
a first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 w...
-
1:31:25
precision medicine in cd30- and cd123-expressing hematologic cancers